Jan. 17, 2024
- Our clinical trial has the1st SMC meeting today to discuss the clinical data of the 3 subjects at the lowest dose level of 0.2 mg/kg, Schedule A (once/week). All the voting members of the SMC voted to advance to the next dose level at 0.5 mg/kg, Schedule A (once/week) due to no DLT observed during DLT observation period at 0.2 mg/kg, Schedule A (once/week).